help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by March, S.
Right arrow Articles by Engel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by March, S.
Right arrow Articles by Engel, P.
(American Journal of Pathology. 2007;170:176-187.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.051212

Identification and Functional Characterization of the Hepatic Stellate Cell CD38 Cell Surface Molecule

Sandra March*, Mariona Graupera{dagger}, María Rosa Sarrias*{ddagger}, Francisco Lozano*{ddagger}, Pilar Pizcueta*, Jaume Bosch{dagger} and Pablo Engel*

From the Immunology Unit,* Department of Cellular Biology and Pathology, Medical School, University of Barcelona; and the Hepatic Hemodynamic Laboratory,{dagger} Liver Unit, Servei d’Immunologia,{ddagger} Hospital Clinic, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain

The activation of hepatic stellate cells (HSCs) is a critical event in hepatic fibrosis, because these cells are the main producers of extracellular matrix proteins in the liver and contribute to the modulation of inflammatory responses via the secretion of several cytokines and the expression of adhesion molecules. The goal of the present study was to characterize cell surface proteins that regulate HSC activation. To this end, a panel of monoclonal antibodies (mAbs) was generated. mAb 14.27 recognized a protein of 45 kd that was highly expressed on HSCs. Affinity purification of this protein followed by sequencing revealed that protein to be CD38. We subsequently demonstrated that CD38 was constitutively expressed by HSCs and that its expression increased after in vitro and in vivo activation. mAb 14.27 induced an increase in cytosolic Ca2+ levels in HSCs, showing that it functions as an agonistic antibody. Moreover, the effects mediated by the CD38 mAb included induction of the proinflammatory cytokine interleukin-6 and up-regulation of the adhesion molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and neural cell adhesion molecule. Collectively, our data suggest that CD38 can act as a regulator of HSC activation and effector functions.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. Zucchetto, D. Benedetti, C. Tripodo, R. Bomben, M. Dal Bo, D. Marconi, F. Bossi, D. Lorenzon, M. Degan, F. M. Rossi, et al.
CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival
Cancer Res., May 1, 2009; 69(9): 4001 - 4009.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Shen and A. Yen
c-Cbl Interacts with CD38 and Promotes Retinoic Acid-Induced Differentiation and G0 Arrest of Human Myeloblastic Leukemia Cells
Cancer Res., November 1, 2008; 68(21): 8761 - 8769.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. L. Friedman
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Physiol Rev, January 1, 2008; 88(1): 125 - 172.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.